Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells

Cited by (115)

Items 101–115 of 115

1. CD4+ T-cell immunity to Bordetella pertussis
   Jesse M. Hall, Justin B. Defalco, Purnima Dubey · 2026 · Discover Immunity.
2. Demyelination Lesions Do Not Correlate with Clinical Manifestations by Bordetella pertussis Toxin Concentrations
   Maiara Carolina Perussolo, Bassam Felipe Mogharbel, Cláudia Sayuri Saçaki, Dilcele Silva Moreira Dziedzic, Seigo Nagashima, Leanderson Franco de Meira, Luiz César Guarita-Souza, Lúcia de Noronha, Katherine Athayde Teixeira de Carvalho · 2022 · Life
3. Cough Hypersensitivity Syndrome Following Whooping Cough Showing Persistent Hypercytokinemia with Autoimmune Feature in Relation to Genetic Hypohaptoglobinemia: a Case Report
   Kouko Hidaka, Yukiko Kawanami, Ichiko Mizuguchi · 2022 · SN Comprehensive Clinical Medicine
4. Immunization With Recombinant Myelin Oligodendrocyte Glycoprotein Identifies Autoreactive T Cells As A Limiting Factor In Autoreactive Germinal Center Maintenance
   Rajiv W. Jain · 2018 · Scholarship@Western (Western University)
5. Overview of Mechanisms Underlying Neuroimmune Diseases
   Sandip Ashok Sonar, Girdhari Lal · 2024 · Springer eBooks
6. miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases
   Norifumi Iijima, Masaya Yamaguchi, Tomoya Hayashi, Yuxiang Rui, Yuta Ohira, Yoichi Miyamoto, Masaaki Niino, Tatsusada Okuno, Osamu Suzuki, Masahiro Oka et al. · 2024 · Journal of Autoimmunity
7. Overview of Mechanisms Underlying Neuroimmune Diseases
   Sandip Ashok Sonar, Girdhari Lal · 2024 · Springer eBooks
8. Attenuating the experimental autoimmune encephalomyelitis model improves preclinical evaluation of candidate multiple sclerosis therapeutics
   Vernise J.T. Lim, Melanie Murphy, W. Stephen Penrose, Coral G. Warr, Maria-Cristina Keightley, Jacqueline Monique Orian · 2025 · Animal Models and Experimental Medicine
9. Additional file 1 of High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro
   Sasha GN Soldati, Alexander Bär, Mykhailo Vladymyrov, Dale Glavin, James L. McGrath, Fabien Gosselet, Hideaki Nishihara, Susan E. Goelz, Engelhardt, Britta · 2023 · Figshare
10. Additional file 7 of High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro
    Sasha GN Soldati, Alexander Bär, Mykhailo Vladymyrov, Dale Glavin, James L. McGrath, Fabien Gosselet, Hideaki Nishihara, Susan E. Goelz, Engelhardt, Britta · 2023 · Figshare
11. TSSP, une protéase limitant l’apprêtement de certains antigènes du soi : étude des mécanismes impliqués et de leurs impacts sur le développement de l’encéphalomyélite auto-immune expérimentale
    Maeva Girard · 2018 · theses.fr (ABES)
12. Regulation of the T cell response in Multiple Sclerosis
    Naïl Benallegue · 2021 · theses.fr (ABES)
13. Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE)
    Arpita Deb, James Matthew Nichols, Alicia K. Olivier, Josie Baird, Chisom Akaniru, Barbara L.F. Kaplan · 2026 · Journal of Neuroimmunology
14. Protective effects of histamine H4 receptor antagonist on the inflammatory responses in B cells in a mouse model of multiple sclerosis.
    H. Al-Mazroua, Hussain N. Alhamami, A. Nadeem, M. A. Ansari, S. Bakheet, S. Attia, W. Sarawi, H. Alomar, A. Alsaad, Ali A. Alshamrani et al. · 2026 · Immunopharmacology and immunotoxicology
15. Use of animal models to understand CNS neuroimmunology — guidance from the International Society for Neuroimmunology White Paper Task Force
    Jennifer L. Gommerman, Katerina Akassoglou, Sergio E. Baranzini, Burkhard Becher, Fabienne Brilot, Gonçalo Castelo‐Branco, Shannon E. Dunn, Maryam Faiz, Alexander Flügel, Nader Ghasemlou et al. · 2026 · Nature Reviews Neurology